Carl Zeiss Case Studies High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma iCare COMPASS Automated Perimeter

Carl Zeiss Case Studies High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma iCare COMPASS Automated Perimeter

View More Cataract & Refractive Cornea Gene Therapy Glaucoma Inflammation & Infection Paediatrics Retina

Cataract & Refractive Cornea Gene Therapy Glaucoma Inflammation & Infection Paediatrics Retina

Medical World News

Eyeviews Medical World News Podcasts Rapid Readouts Viewpoints

Digital Edition

Supplements And Featured Publications

Digital Edition Supplements And Featured Publications

Conference Coverage

Conference Listing

Sponsored Resources

Zeiss Case Studies

Sponsored Resources Zeiss Case Studies

Print Subscription

eNewsletter Print Subscription

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2022 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Carl Zeiss Case Studies
High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma
iCare COMPASS Automated Perimeter

ClinicalSee All >

Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2022 MJH Life Sciences^™ and Opthalmology Times Europe. All rights reserved.

Deep sclerectomy best bet in previous failed surgery cases

February 1, 2009

Deep sclerectomy with MMC is safer and more effective than trabeculectomy or tube surgery, according to Dr Nitin Anand.

Related Content:

ArticlesGlaucoma

Self-plugging microneedles may improve drug delivery in the eye

Self-plugging microneedles may improve drug delivery in the eye

Newly identified molecular mechanism may lead to more therapies for retinitis pigmentosa

Newly identified molecular mechanism may lead to more therapies for retinitis pigmentosa

Ebola, other viruses may be housed in retina cells

Ebola, other viruses may be housed in retina cells